The Nucleic Acid Therapy Accelerator (NATA) is a new national research initiative with a mission to accelerate the development of nucleic acid therapeutics, while firmly anchoring the nucleic acid (NA) therapy industry in the UK for many years to come. 

The NATA will be at the Harwell Science and Innovation Campus, at the heart of a growing Life Health Cluster. It will benefit from and contribute to the campus’ world-class scientific talent, ecosystem and related facilities, including the Research Complex at Harwell and the new Rosalind Franklin Institute.

Life Sciences

Research

Therapeutics

NATA - Nucleic Acid Therapy Accelerator

Nick Lench

Anne Willis

Alison Smith

Shalini Andersson

Laura Sepp - Lorenzino

The Research and Development Team at Nucleic Acid Therapy Accelerator (NATA) focuses on pioneering the discovery, design, and synthesis of innovative nucleic acid-based therapeutics. Leveraging the extensive expertise of leading scientists and cutting-edge facilities at the Harwell Science and Innovation Campus, the team aims to advance the therapeutic potential of nucleic acids, addressing critical medical needs and propelling the UK to the forefront of the NA therapy industry.

Research and Development Team

Leadership Team

Research and Development Team

About

Team members

Other teams at NATA - Nucleic Acid Therapy Accelerator

Leadership Team